EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 22019D0740

Decision of the EEA Joint Committee No 133/2017 of 7 July 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/740]

OJ L 128, 16/05/2019, p. 26–27 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/dec/2019/740/oj

16.5.2019   

EN

Official Journal of the European Union

L 128/26


DECISION OF THE EEA JOINT COMMITTEE

No 133/2017

of 7 July 2017

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/740]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1)

Commission Implementing Regulation (EU) 2017/157 of 30 January 2017 renewing the approval of the active substance thiabendazole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (1) is to be incorporated into the EEA Agreement.

(2)

Commission Implementing Regulation (EU) 2017/239 of 10 February 2017 approving the active substance oxathiapiprolin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) is to be incorporated into the EEA Agreement.

(3)

Commission Implementing Regulation (EU) 2017/243 of 10 February 2017 amending Implementing Regulation (EU) No 686/2012 as regards the co-rapporteur Member State for the active substance metaldehyde (3) is to be incorporated into the EEA Agreement.

(4)

Commission Implementing Regulation (EU) 2017/244 of 10 February 2017 concerning the non-renewal of approval of the active substance linuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.

(5)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

Chapter XV of Annex II to the EEA Agreement shall be amended as follows:

1.

The following indents are added to point 13a (Commission Implementing Regulation (EU) No 540/2011):

‘—

32017 R 0157: Commission Implementing Regulation (EU) 2017/157 of 30 January 2017 (OJ L 25, 31.1.2017, p. 5),

32017 R 0239: Commission Implementing Regulation (EU) 2017/239 of 10 February 2017 (OJ L 36, 11.2.2017, p. 39),

32017 R 0244: Commission Implementing Regulation (EU) 2017/244 of 10 February 2017 (OJ L 36, 11.2.2017, p. 54).’

2.

The following indent is added to point 13zzze (Commission Implementing Regulation (EU) No 686/2012):

‘—

32017 R 0243: Commission Implementing Regulation (EU) 2017/243 of 10 February 2017 (OJ L 36, 11.2.2017, p. 53).’

3.

The following points are inserted after point 13zzzzzzs (Commission Implementing Regulation (EU) 2016/1826):

‘13zzzzzzt.

32017 R 0157: Commission Implementing Regulation (EU) 2017/157 of 30 January 2017 renewing the approval of the active substance thiabendazole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 25, 31.1.2017, p. 5).

13zzzzzzu.

32017 R 0239: Commission Implementing Regulation (EU) 2017/239 of 10 February 2017 approving the active substance oxathiapiprolin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 36, 11.2.2017, p. 39).

13zzzzzzv.

32017 R 0244: Commission Implementing Regulation (EU) 2017/244 of 10 February 2017 concerning the non-renewal of approval of the active substance linuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 36, 11.2.2017, p. 54).’

Article 2

The texts of Implementing Regulations (EU) 2017/157, (EU) 2017/239, (EU) 2017/243 and (EU) 2017/244 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 8 July 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 7 July 2017.

For the EEA Joint Committee

The President

Sabine MONAUNI


(1)   OJ L 25, 31.1.2017, p. 5.

(2)   OJ L 36, 11.2.2017, p. 39.

(3)   OJ L 36, 11.2.2017, p. 53.

(4)   OJ L 36, 11.2.2017, p. 54.

(*1)  No constitutional requirements indicated.


Top